Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy Adults
Clinical trial NCT02860806 · COMPLETED
Trial details
- NCT number
- NCT02860806
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-08
- Primary completion
- 2017-06-06
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.